Citation data

CrossRef

Works that cite this article, indexed by Crossref.

35 resultsUpdated August 09, 2026
1

Machine Learning Study: From the Toxicity Studies to Tetrahydrocannabinol Effects on Parkinson's Disease

Future Medicinal Chemistry 15(4) (2023)

Mehmet Ali Yucel; Ibrahim Ozcelik; Oztekin Algul

3

Structure-Based Design, Optimization, and Development of [18F]LU13: A Novel Radioligand for Cannabinoid Receptor Type 2 Imaging in the Brain with PET

Journal of Medicinal Chemistry 65(13) (2022)

Daniel Gündel; Winnie Deuther-Conrad; Lea Ueberham; Sarandeep Kaur; Elina Otikova; Rodrigo Teodoro; Magali Toussaint; Thu Hang Lai; Oliver Clauß; Matthias Scheunemann; Guy Bormans; Michael Bachmann; Klaus Kopka; Peter Brust; Rareş-Petru Moldovan

4

Interplay between the Glymphatic System and the Endocannabinoid System: Implications for Brain Health and Disease

International Journal of Molecular Sciences 24(24) (2023)

Juan F. Osuna-Ramos; Josué Camberos-Barraza; Laura E. Torres-Mondragón; Ángel R. Rábago-Monzón; Alejandro Camacho-Zamora; Marco A. Valdez-Flores; Carla E. Angulo-Rojo; Alma M. Guadrón-Llanos; Verónica J. Picos-Cárdenas; Loranda Calderón-Zamora; Javier A. Magaña-Gómez; Claudia D. Norzagaray-Valenzuela; Feliznando I. Cárdenas-Torres; Alberto K. De la Herrán-Arita

5

The therapeutic role of cannabinoid receptors and its agonists or antagonists in Parkinson's disease

Progress in Neuro-Psychopharmacology and Biological Psychiatry 96 (2020)

Qi-Wen Han; Yu-He Yuan; Nai-Hong Chen

6

Cannabinoids, the Endocannabinoid System, and Cognitive Functions: Enemies or Friends?

Neuroscience and Behavioral Physiology 51(7) (2021)

V. F. Kitchigina

7

Mechanistic insights into the protective effect of paracetamol against rotenone-induced Parkinson’s disease in rats: Possible role of endocannabinoid system modulation

International Immunopharmacology 94 (2021)

Aya Yassin Labib; Ramy M. Ammar; Reem N. El-Naga; Alshaymaa Amin Zaki El-Bahy; Mariane G. Tadros; Haidy E. Michel

8

Medicinal Chemistry, Pharmacology, and Potential Therapeutic Benefits of Cannabinoid CB2Receptor Agonists

Chemical Reviews 116(2) (2016)

Mojgan Aghazadeh Tabrizi; Pier Giovanni Baraldi; Pier Andrea Borea; Katia Varani

9

Polyunsaturated fatty acids and endocannabinoids in health and disease

Nutritional Neuroscience 21(10) (2018)

Hércules Rezende Freitas; Alinny Rosendo Isaac; Renato Malcher-Lopes; Bruno Lourenço Diaz; Isis Hara Trevenzoli; Ricardo Augusto De Melo Reis

10

Cannabinoid Actions on Neural Stem Cells: Implications for Pathophysiology

Molecules 24(7) (2019)

Rui S. Rodrigues; Diogo M. Lourenço; Sara L. Paulo; Joana M. Mateus; Miguel F. Ferreira; Francisco M. Mouro; João B. Moreira; Filipa F. Ribeiro; Ana M. Sebastião; Sara Xapelli

11

Development of [18F]LU14 for PET Imaging of Cannabinoid Receptor Type 2 in the Brain

International Journal of Molecular Sciences 22(15) (2021)

Rodrigo Teodoro; Daniel Gündel; Winnie Deuther-Conrad; Lea Ueberham; Magali Toussaint; Guy Bormans; Peter Brust; Rareş-Petru Moldovan

12

Distant neuroinflammation acutely induced by focal brain injury and its control by endocannabinoid system

Experimental Neurology 373 (2024)

Anna A. Karan; Yulia S. Spivak; Elena M. Suleymanova; Konstantin A. Gerasimov; Alex P. Bolshakov; Lyudmila V. Vinogradova

13

Interaction between Cannabinoid Type 1 and Type 2 Receptors in the Modulation of Subventricular Zone and Dentate Gyrus Neurogenesis

Frontiers in Pharmacology 8 (2017)

Rui S. Rodrigues; Filipa F. Ribeiro; Filipa Ferreira; Sandra H. Vaz; Ana M. Sebastião; Sara Xapelli

14

Cannabinoids and the expanded endocannabinoid system in neurological disorders

Nature Reviews Neurology 16(1) (2020)

Luigia Cristino; Tiziana Bisogno; Vincenzo Di Marzo

15

Synaptopathic mechanisms of neurodegeneration and dementia: Insights from Huntington’s disease

Progress in Neurobiology 153 (2017)

Shiraz Tyebji; Anthony J. Hannan

17

Structural Optimization of 4-Chlorobenzoylpiperidine Derivatives for the Development of Potent, Reversible, and Selective Monoacylglycerol Lipase (MAGL) Inhibitors

Journal of Medicinal Chemistry 59(22) (2016)

Carlotta Granchi; Flavio Rizzolio; Stefano Palazzolo; Sara Carmignani; Marco Macchia; Giuseppe Saccomanni; Clementina Manera; Adriano Martinelli; Filippo Minutolo; Tiziano Tuccinardi

18

Cannabinoid Receptor 2 Signaling in Neurodegenerative Disorders: From Pathogenesis to a Promising Therapeutic Target

Frontiers in Neuroscience 11 (2017)

Tommaso Cassano; Silvio Calcagnini; Lorenzo Pace; Federico De Marco; Adele Romano; Silvana Gaetani

21

Potential Neuroprotective Effect of Cannabinoids in COVID-19 Patients

Current Topics in Medicinal Chemistry 22(16) (2022)

José Luis Cortes-Altamirano; Ariadna Yáñez-Pizaña; Samuel Reyes-Long; González-Maciel Angélica; Cindy Bandala; Herlinda Bonilla-Jaime; Alfonso Alfaro-Rodríguez

22

Endocannabinoids and endocannabinoid-related mediators: Targets, metabolism and role in neurological disorders

Progress in Lipid Research 62 (2016)

Fabio Arturo Iannotti; Vincenzo Di Marzo; Stefania Petrosino

23

Cannabinoid CB2 Receptors in Neurodegenerative Proteinopathies: New Insights and Therapeutic Potential

Biomedicines 10(12) (2022)

Barbara Vuic; Tina Milos; Lucija Tudor; Marcela Konjevod; Matea Nikolac Perkovic; Maja Jazvinscak Jembrek; Gordana Nedic Erjavec; Dubravka Svob Strac

24

Novel Psychoactive Substances in Young Adults with and without Psychiatric Comorbidities

BioMed Research International 2014 (2014)

Giovanni Martinotti; Matteo Lupi; Tiziano Acciavatti; Eduardo Cinosi; Rita Santacroce; Maria Salvina Signorelli; Laura Bandini; Giulia Lisi; Diego Quattrone; Paola Ciambrone; Andrea Aguglia; Federica Pinna; Salvatore Calò; Luigi Janiri; Massimo di Giannantonio

25

Terpenoids, Cannabimimetic Ligands, beyond the Cannabis Plant

Molecules 25(7) (2020)

Elaine C. D. Gonçalves; Gabriela M. Baldasso; Maíra A. Bicca; Rodrigo S. Paes; Raffaele Capasso; Rafael C. Dutra

26

Molecular Targets of Cannabidiol in Neurological Disorders

Neurotherapeutics 12(4) (2015)

Clementino Ibeas Bih; Tong Chen; Alistair V.W. Nunn; Michaël Bazelot; Mark Dallas; Benjamin J. Whalley

27

Pyrazole phenylcyclohexylcarbamates as inhibitors of human fatty acid amide hydrolases (FAAH)

European Journal of Medicinal Chemistry 97 (2015)

Mojgan Aghazadeh Tabrizi; Pier Giovanni Baraldi; Emanuela Ruggiero; Giulia Saponaro; Stefania Baraldi; Romeo Romagnoli; Adriano Martinelli; Tiziano Tuccinardi

28

Complementary and Alternative Therapies in Amyotrophic Lateral Sclerosis

Neurologic Clinics 33(4) (2015)

Richard S. Bedlack; Nanette Joyce; Gregory T. Carter; Sabrina Paganoni; Chafic Karam

31

Cannabidiol and Other Cannabinoids in Demyelinating Diseases

International Journal of Molecular Sciences 22(6) (2021)

Carmen Navarrete; Adela García-Martín; Alain Rolland; Jim DeMesa; Eduardo Muñoz

32

Potential Therapeutic Targets of the Endocannabinoid System in Common Neurodegenerative Disorders and Organic Acidemias

Journal of Inborn Errors of Metabolism and Screening 5 (2017)

Gabriela Aguilera; Abel Santamaria

33

Methamphetamine administration impairs behavior, memory and underlying signaling pathways in the hippocampus

Behavioural Brain Research 379 (2020)

Sakineh Alizadeh Golsorkhdan; Mahdi Eskandarian Boroujeni; Abbas Aliaghaei; Mohammad Amin Abdollahifar; Afshar Ramezanpour; Reza Nejatbakhsh; Iraj Jafari Anarkooli; Elahe Barfi; Mohammad Javad Fridoni